$EAPH Announces Due Diligence Update

Easton Pharmaceuticals Provides Medicated Markets Due Diligence Update With the Disclosure of…

$NRTI To Attend 2015 ECRM Tradeshow in Baltimore, MD

Inergetics Showcases Superior Product and Marketing Innovation at the 2015 ECRM Tradeshow…

$XXII Establishes Trade Partners Program

22nd Century Group Establishes Trade Partners Program to Promote the Sale of…

$FWDG Give Shareholder Update

FutureWorld (FWDG) Provides Shareholder Update I – 2015 Corporate Progress Report –…

$GBLX Partners with Fuzhou Seechance Holding

GrowBLOX Sciences Partners with Fuzhou Seechance Holding for Production of its Proprietary…

$INSY Initiates Five Phase III Clinical Trials

Insys Therapeutics to Initiate Five Phase III Clinical Trials in 2015 PHOENIX,…

$OXIS Announces Exclusive Licensing for “P62 Chemical Agents and Multiple Myeloma Therapeutics”

Oxis Biotech Executes Worldwide Exclusive Patent Licensing “P62 Chemical Agents and Multiple…

If You Could Have Bought $GWPH & $INSY at 0.02 Would You?

Connecting The Dots In the OTC and Pinksheet markets investors have been…